{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:26:14Z","timestamp":1791721574733,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52473142"],"award-info":[{"award-number":["52473142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52033006"],"award-info":[{"award-number":["52033006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jconrel.2025.113704","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T15:24:40Z","timestamp":1744039480000},"page":"113704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Photothermal treatment of prostate tumor with micellar indocyanine green and napabucasin to co-ablate cancer cells and cancer stem cells"],"prefix":"10.1016","volume":"382","author":[{"given":"Yanyi","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songsong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2025.113704_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10305","key":"10.1016\/j.jconrel.2025.113704_bb0010","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","article-title":"Prostate cancer","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jconrel.2025.113704_bb0015","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1200\/JCO.2014.58.2973","article-title":"Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT","volume":"33","author":"Klotz","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.jconrel.2025.113704_bb0020","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1158\/1078-0432.CCR-15-2956","article-title":"Defining a population of stem-like human prostate cancer cells that can generate and propagate castration-resistant prostate cancer","volume":"22","author":"Chen","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113704_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188887","article-title":"Cancer stem cell in prostate cancer progression, metastasis and therapy resistance","volume":"1878","author":"Verma","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113704_bb0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.20517\/cdr.2022.07","article-title":"Role of prostate cancer stem-like cells in the development of antiandrogen resistance","volume":"5","author":"Kushwaha","year":"2022","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.jconrel.2025.113704_bb0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.addr.2015.08.005","article-title":"Tumor microenvironment for cancer stem cells","volume":"99","author":"Kise","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113704_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Sign. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113704_bb0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-020-00430-1","article-title":"Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents","volume":"6","author":"Zhou","year":"2021","journal-title":"Sign. Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113704_bb0050","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/14712598.2011.573780","article-title":"Cancer stem cells: the development of new cancer therapeutics","volume":"11","author":"Scatena","year":"2011","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113704_bb0055","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1002\/jcb.26572","article-title":"GANT-61 and GDC-0449 induce apoptosis of prostate cancer stem cells through a GLI-dependent mechanism","volume":"119","author":"Tong","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113704_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12943-023-01825-8","article-title":"STAT3\/LKB1 controls metastatic prostate cancer by regulating mTORC1\/CREB pathway","volume":"22","author":"Pencik","year":"2023","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113704_bb0065","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.3390\/ijms24054722","article-title":"Overcoming acquired drug resistance to Cancer therapies through targeted STAT3 inhibition","volume":"24","author":"Singh","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113704_bb0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S2468-1253(18)30009-8","article-title":"Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial","volume":"3","author":"Jonker","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"15","key":"10.1016\/j.jconrel.2025.113704_bb0075","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.3390\/molecules28155678","article-title":"The anticancer effect of Napabucasin (BBI608), a natural naphthoquinone","volume":"28","author":"Shao","year":"2023","journal-title":"Molecules"},{"issue":"22","key":"10.1016\/j.jconrel.2025.113704_bb0080","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1158\/1078-0432.CCR-20-1803","article-title":"Multicenter phase I\/II trial of Napabucasin and Pembrolizumab in patients with metastatic colorectal cancer (EPOC1503\/SCOOP trial)","volume":"26","author":"Kawazoe","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113704_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101897","article-title":"Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial","volume":"58","author":"Bekaii-Saab","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113704_bb0090","first-page":"100","article-title":"Napabucasin plus FOLFIRI in patients with previously treated metastatic colorectal cancer: results from the open-label, randomized phase III CanStem303C study","volume":"22","author":"Shah","year":"2023","journal-title":"Clin. Colorectal Cancer"},{"issue":"17","key":"10.1016\/j.jconrel.2025.113704_bb0095","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1158\/1078-0432.CCR-21-4021","article-title":"Randomized, double-blind, placebo-controlled phase III study of paclitaxel \u00b1 Napabucasin in pretreated advanced gastric or gastroesophageal junction adenocarcinoma","volume":"28","author":"Shah","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113704_bb0100","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/cancers11091331","article-title":"Elimination of SOX2\/OCT4-associated prostate cancer stem cells blocks tumor development and enhances therapeutic response","volume":"11","author":"Vaddi","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113704_bb0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41565-020-00793-0","article-title":"A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells","volume":"16","author":"Shen","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113704_bb0110","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1039\/D4BM00057A","article-title":"Photothermal therapy: a novel potential treatment for prostate cancer","volume":"12","author":"Dong","year":"2024","journal-title":"Biomater. Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2025.113704_bb0115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113704_bb0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2023.12.037","article-title":"Hydrogel design to overcome thermal resistance and ROS detoxification in photothermal and photodynamic therapy of cancer","volume":"366","author":"Jeong","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113704_bb0125","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1038\/s41467-022-30306-7","article-title":"Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113704_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122766","article-title":"Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy","volume":"313","author":"Wang","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113704_bb0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12951-023-01792-8","article-title":"Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy","volume":"21","author":"Jing","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"20","key":"10.1016\/j.jconrel.2025.113704_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305832","article-title":"In situ hydrogel modulates cDC1-based antigen presentation and Cancer Stemness to enhance cancer vaccine efficiency","volume":"11","author":"Gao","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.113704_bb0145","first-page":"61","article-title":"Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative \u201ccold\u201d triple-negative breast cancer","volume":"25","author":"Guo","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2025.113704_bb0150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.actbio.2023.08.043","article-title":"Integrin-targeting disulfide-crosslinked micellar docetaxel eradicates lung and prostate cancer patient-derived xenografts","volume":"170","author":"Ni","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.113704_bb0155","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jconrel.2021.12.002","article-title":"Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer","volume":"341","author":"Qiu","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113704_bb0160","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231703","article-title":"Emerging Theranostics for prostate cancer and a model of prostate-specific membrane antigen therapy","volume":"311","author":"Jewell","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.jconrel.2025.113704_bb0165","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jconrel.2024.09.040","article-title":"PSMA and Sigma-1 receptor dual-targeted peptide mediates superior radionuclide imaging and therapy of prostate cancer","volume":"375","author":"Huangfu","year":"2024","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113704_bb0170","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177\u2013PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113704_bb0175","first-page":"327","article-title":"FDA approves first PSMA-targeted radiopharmaceutical","volume":"21","author":"Mullard","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113704_bb0180","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nnano.2011.166","article-title":"Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size","volume":"6","author":"Cabral","year":"2011","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113704_bb0185","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1021\/acsnano.5b02017","article-title":"The role of micelle size in tumor accumulation, penetration, and treatment","volume":"9","author":"Wang","year":"2015","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113704_bb0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12943-017-0596-9","article-title":"Epigenetics in cancer stem cells","volume":"16","author":"Toh","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113704_bb0195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12951-021-01080-3","article-title":"Recent advances in selective photothermal therapy of tumor","volume":"19","author":"Zhao","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113704_bb0200","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1073\/pnas.1424171112","article-title":"Suppression of cancer relapse and metastasis by inhibiting cancer stemness","volume":"112","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113704_bb0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13046-019-1289-6","article-title":"Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells","volume":"38","author":"Han","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113704_bb0210","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2967\/jnumed.120.246041","article-title":"Immune-checkpoint blockade enhances 225Ac-PSMA617 efficacy in a mouse model of prostate cancer","volume":"62","author":"Czernin","year":"2021","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113704_bb0215","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-16-1536","article-title":"Surgery for cancer: a trigger for metastases","volume":"77","author":"Tohme","year":"2017","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113704_bb0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10585-018-9896-8","article-title":"Potential impact of invasive surgical procedures on primary tumor growth and metastasis","volume":"35","author":"Alieva","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113704_bb0225","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2013.10.029","article-title":"Mechanisms governing metastatic dormancy and reactivation","volume":"155","author":"Giancotti","year":"2013","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.jconrel.2025.113704_bb0230","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1158\/2159-8290.CD-23-0331","article-title":"Transposable elements are co-opted as oncogenic regulatory elements by lineage-specific transcription factors in prostate cancer","volume":"13","author":"Grillo","year":"2023","journal-title":"Cancer Discov."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925003244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925003244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:05:39Z","timestamp":1777871139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925003244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"alternative-id":["S0168365925003244"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113704","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Photothermal treatment of prostate tumor with micellar indocyanine green and napabucasin to co-ablate cancer cells and cancer stem cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113704"}}